We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

Universities abroad experiment with no-fee licensing to drive biotech partnerships

  • Shook Hardy & Bacon LLP
  • -
  • Australia, Canada, European Union, United Kingdom, USA
  • -
  • May 16 2013

Universities in Australia, Canada, Europe, and the United Kingdom have reportedly embraced a 2010 Glasgow University initiative under which companies

IP challenges for the personalised medicines industry - gene claims (part 1)

  • Barker Brettell LLP
  • -
  • European Union, United Kingdom, USA
  • -
  • May 9 2013

When you go to the doctor you expect to be asked a lot of questions about your symptoms and your lifestyle, as the doctor builds up a clinical

U.K. jumps on “pay-to-delay” bandwagon

  • Fish & Richardson PC
  • -
  • United Kingdom, USA
  • -
  • April 24 2013

The U.K. Office of Fair Trading ("OFT") jumped on the "pay-to-delay" bandwagon last week when it issued a "Statement of Objections," indicating a

Global Pricing Newsletter: volume two

  • Sidley Austin LLP
  • -
  • China, Global, United Kingdom, USA
  • -
  • February 27 2013

Pharmaceutical and biologic manufacturers operate in an increasingly global economy where legal developments in one market may have cascading impacts

NHS wants patient records

  • Jackson Lewis LLP
  • -
  • United Kingdom, USA
  • -
  • February 4 2013

The National Health Service, which represents a significant part of the United Kingdom's government-run health system, is looking to go paperless. In

BLG Monthly Update

  • Borden Ladner Gervais LLP
  • -
  • Argentina, Australia, Canada, United Kingdom, USA
  • -
  • December 19 2012

The BLG Monthly Update is a digest of recent developments in the law which Neil Guthrie, our National Director of Research, thinks you will find

FCPA anti-corruption developments: 2012 end of summer round-up

  • Morrison & Foerster LLP
  • -
  • China, France, Global, Haiti, India, Mexico, United Kingdom, USA
  • -
  • October 10 2012

While the temperatures rose this summer, the number of Foreign Corrupt Practices Act enforcement actions seems to have cooled off for the first time in the last five years

Rudd Center study examines obesity-related health messaging

  • Shook Hardy & Bacon LLP
  • -
  • Australia, United Kingdom, USA
  • -
  • September 14 2012

Researchers with Yale University’s Rudd Center for Food Policy and Obesity have published a study purportedly assessing the effectiveness of “major obesity public health campaigns from the United States, the United Kingdom and Australia.”

Managing your risks under global anti-corruption regimes

  • Piper Alderman
  • -
  • Australia, United Kingdom, USA
  • -
  • September 13 2012

Pharmaceutical and medical device companies operate in a stringent regulatory environment

PIP and hips. Do we need a new regulatory system for medical devices?

  • Winston & Strawn LLP
  • -
  • European Union, United Kingdom, USA
  • -
  • July 25 2012

Recently two classes of implantable devices have come under a cloud in Europe